

© 2024 LYNX-Werbemitteilung - Bitte beachten Sie den Haftungsausschluss
Realtime | Geld | Brief | Zeit |
---|---|---|---|
447,00 | 449,70 | 31.03. | |
447,75 | 448,75 | 31.03. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
00:06 | Demystifying Vertex Pharmaceuticals: Insights From 17 Analyst Reviews | ||
Mo | Vertex Discontinues Development Of Type 1 Diabetes Candidate After Disappointing Data | ||
Mo | Vertex Cell Therapy Misses in the Clinic, But It Has Other Shots on the Type 1 Diabetes Goal | ||
Mo | Vertex non-opioid painkiller Journavx gets mixed ICER review | ||
Mo | Vertex halts development of diabetes cell therapy after trial failure |